<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35511862</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>09</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1549-4918</ISSN><JournalIssue CitedMedium="Internet"><Volume>40</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>03</Day></PubDate></JournalIssue><Title>Stem cells (Dayton, Ohio)</Title><ISOAbbreviation>Stem Cells</ISOAbbreviation></Journal><ArticleTitle>Exploring Motor Neuron Diseases Using iPSC Platforms.</ArticleTitle><Pagination><StartPage>2</StartPage><EndPage>13</EndPage><MedlinePgn>2-13</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/stmcls/sxab006</ELocationID><Abstract><AbstractText>The degeneration of motor neurons is a pathological hallmark of motor neuron diseases (MNDs), but emerging evidence suggests that neuronal vulnerability extends well beyond this cell subtype. The ability to assess motor function in the clinic is limited to physical examination, electrophysiological measures, and tissue-based or neuroimaging techniques which lack the resolution to accurately assess neuronal dysfunction as the disease progresses. Spinal muscular atrophy (SMA), spinal and bulbar muscular atrophy (SBMA), hereditary spastic paraplegia (HSP), and amyotrophic lateral sclerosis (ALS) are all MNDs with devastating clinical outcomes that contribute significantly to disease burden as patients are no longer able to carry out normal activities of daily living. The critical need to accurately assess the cause and progression of motor neuron dysfunction, especially in the early stages of those diseases, has motivated the use of human iPSC-derived motor neurons (hiPSC-MN) to study the neurobiological mechanisms underlying disease pathogenesis and to generate platforms for therapeutic discovery and testing. As our understanding of MNDs has grown, so too has our need to develop more complex in vitro models which include hiPSC-MN co-cultured with relevant non-neuronal cells in 2D as well as in 3D organoid and spheroid systems. These more complex hiPSC-derived culture systems have led to the implementation of new technologies, including microfluidics, multielectrode array, and machine learning which offer novel insights into the functional correlates of these emerging model systems.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Johns</LastName><ForeName>Alexandra E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maragakis</LastName><ForeName>Nicholas J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Department of Neurology, Johns Hopkins University, Baltimore, MD, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>1R01NS117604-01</GrantID><Acronym>NH</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013486">Research Support, U.S. Gov't, Non-P.H.S.</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Stem Cells</MedlineTA><NlmUniqueID>9304532</NlmUniqueID><ISSNLinking>1066-5099</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000203" MajorTopicYN="N">Activities of Daily Living</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057026" MajorTopicYN="Y">Induced Pluripotent Stem Cells</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016472" MajorTopicYN="Y">Motor Neuron Disease</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="Y">Muscular Atrophy, Spinal</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">hereditary spastic paraplegia</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">spinal and bulbar muscular atrophy</Keyword><Keyword MajorTopicYN="N">spinal muscular atrophy</Keyword><Keyword MajorTopicYN="N">stem cell</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>5</Month><Day>5</Day><Hour>13</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>5</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35511862</ArticleId><ArticleId IdType="pmc">PMC9199844</ArticleId><ArticleId IdType="doi">10.1093/stmcls/sxab006</ArticleId><ArticleId IdType="pii">6511406</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Genc B, Gozutok O, Ozdinler PH.. Complexity of generating mouse models to study the upper motor neurons: let us shift focus from mice to neurons. Int J Mol Sci. 2019;20(16):3848. 10.3390/ijms20163848</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20163848</ArticleId><ArticleId IdType="pmc">PMC6720674</ArticleId><ArticleId IdType="pubmed">31394733</ArticleId></ArticleIdList></Reference><Reference><Citation>Benatar M. Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis. 2007;26:1-13.</Citation><ArticleIdList><ArticleId IdType="pubmed">17300945</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens BM, Ajroud-Driss S, Ma L, Ma YC.. Molecular mechanisms and animal models of spinal muscular atrophy. Biochim Biophys Acta. 2015;1852:685-692. 10.1016/j.bbadis.2014.07.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2014.07.024</ArticleId><ArticleId IdType="pubmed">25088406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X, Song J, Huang H, Chen H, Qian K.. Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells. Stem Cell Res Ther. 2018;9:315. 10.1186/s13287-018-1048-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13287-018-1048-1</ArticleId><ArticleId IdType="pmc">PMC6238404</ArticleId><ArticleId IdType="pubmed">30442180</ArticleId></ArticleIdList></Reference><Reference><Citation>Arlotta P, Molyneaux BJ, Chen J, et al. . Neuronal subtype-specific genes that control corticospinal motor neuron development in vivo. Neuron. 2005;45:207-221. 10.1016/j.neuron.2004.12.036</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2004.12.036</ArticleId><ArticleId IdType="pubmed">15664173</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen B, Wang SS, Hattox AM, et al. . The Fezf2-Ctip2 genetic pathway regulates the fate choice of subcortical projection neurons in the developing cerebral cortex. Proc Natl Acad Sci USA. 2008;105:11382-11387. 10.1073/pnas.0804918105</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0804918105</ArticleId><ArticleId IdType="pmc">PMC2495013</ArticleId><ArticleId IdType="pubmed">18678899</ArticleId></ArticleIdList></Reference><Reference><Citation>Samata B, Takaishi R, Ishii Y, et al. . L1CAM is a marker for enriching corticospinal motor neurons in the developing brain. Front Cell Neurosci. 2020;14:31. 10.3389/fncel.2020.00031</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2020.00031</ArticleId><ArticleId IdType="pmc">PMC7042175</ArticleId><ArticleId IdType="pubmed">32140099</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefebvre S, Burglen L, Reboullet S, et al. . Identification and characterization of a spinal muscular atrophy-determining gene. Cell. 1995;80:155-165. 10.1016/0092-8674(95)90460-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(95)90460-3</ArticleId><ArticleId IdType="pubmed">7813012</ArticleId></ArticleIdList></Reference><Reference><Citation>Crawford TO, Pardo CA.. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis. 1996;3:97-110.</Citation><ArticleIdList><ArticleId IdType="pubmed">9173917</ArticleId></ArticleIdList></Reference><Reference><Citation>Han KJ, Foster DG, Zhang N-Y, et al. . Ubiquitin-specific protease 9x deubiquitinates and stabilizes the spinal muscular atrophy protein-survival motor neuron. J Biol Chem. 2012;287:43741-43752. 10.1074/jbc.M112.372318</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.372318</ArticleId><ArticleId IdType="pmc">PMC3527959</ArticleId><ArticleId IdType="pubmed">23112048</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebert AD, Yu J, Rose FF, et al. . Induced pluripotent stem cells from a spinal muscular atrophy patient. Nature. 2009;457:277-280. 10.1038/nature07677</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature07677</ArticleId><ArticleId IdType="pmc">PMC2659408</ArticleId><ArticleId IdType="pubmed">19098894</ArticleId></ArticleIdList></Reference><Reference><Citation>Adami R, Bottai D.. Spinal muscular atrophy modeling and treatment advances by induced pluripotent stem cells studies. Stem Cell Rev Rep. 2019;15:795-813. 10.1007/s12015-019-09910-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12015-019-09910-6</ArticleId><ArticleId IdType="pubmed">31863335</ArticleId></ArticleIdList></Reference><Reference><Citation>La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH.. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature. 1991;352:77-79. 10.1038/352077a0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/352077a0</ArticleId><ArticleId IdType="pubmed">2062380</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy WR, Alter M, Sung JH.. Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait. Neurology. 1968;18:671-680. 10.1212/wnl.18.7.671</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/wnl.18.7.671</ArticleId><ArticleId IdType="pubmed">4233749</ArticleId></ArticleIdList></Reference><Reference><Citation>Nihei Y, Ito D, Okada Y, et al. . Enhanced aggregation of androgen receptor in induced pluripotent stem cell-derived neurons from spinal and bulbar muscular atrophy. J Biol Chem. 2013;288:8043-8052. 10.1074/jbc.M112.408211</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M112.408211</ArticleId><ArticleId IdType="pmc">PMC3605623</ArticleId><ArticleId IdType="pubmed">23364790</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan G, Sheila M, Chai J, Stanton LW.. Generation of sibling-matched induced pluripotent stem cell lines from spinal and bulbar muscular atrophy patients. Stem Cell Res. 2013;20:30-33. 10.1016/j.scr.2017.02.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2017.02.005</ArticleId><ArticleId IdType="pubmed">28395737</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, Zukosky K, Kats IR, et al. . Stem cell-derived motor neurons from spinal and bulbar muscular atrophy patients. Neurobiol Dis. 2014;70:12-20. 10.1016/j.nbd.2014.05.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2014.05.038</ArticleId><ArticleId IdType="pmc">PMC4172362</ArticleId><ArticleId IdType="pubmed">24925468</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheila M, Narayanan G, Ma S, et al. . Phenotypic and molecular features underlying neurodegeneration of motor neurons derived from spinal and bulbar muscular atrophy patients. Neurobiol Dis. 2019;124:1-13. 10.1016/j.nbd.2018.10.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2018.10.019</ArticleId><ArticleId IdType="pubmed">30391288</ArticleId></ArticleIdList></Reference><Reference><Citation>Onodera K, Shimojo D, Ishihara Y, et al. . Unveiling synapse pathology in spinal bulbar muscular atrophy by genome-wide transcriptome analysis of purified motor neurons derived from disease specific iPSCs. Mol Brain. 2020;13:18. 10.1186/s13041-020-0561-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-020-0561-1</ArticleId><ArticleId IdType="pmc">PMC7029484</ArticleId><ArticleId IdType="pubmed">32070397</ArticleId></ArticleIdList></Reference><Reference><Citation>Cortes CJ, Miranda HC, Frankowski H, et al. . Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA. Nat Neurosci. 2014;17:1180-1189. 10.1038/nn.3787</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3787</ArticleId><ArticleId IdType="pmc">PMC4180729</ArticleId><ArticleId IdType="pubmed">25108912</ArticleId></ArticleIdList></Reference><Reference><Citation>Blackstone C. Converging cellular themes for the hereditary spastic paraplegias. Curr Opin Neurobiol. 2018;51:139-146. 10.1016/j.conb.2018.04.025</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2018.04.025</ArticleId><ArticleId IdType="pmc">PMC6066444</ArticleId><ArticleId IdType="pubmed">29753924</ArticleId></ArticleIdList></Reference><Reference><Citation>Denton KR, Lei L, Grenier J, et al. . Loss of spastin function results in disease-specific axonal defects in human pluripotent stem cell-based models of hereditary spastic paraplegia. Stem Cells. 2014;32:414-423. 10.1002/stem.1569</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.1569</ArticleId><ArticleId IdType="pmc">PMC3947148</ArticleId><ArticleId IdType="pubmed">24123785</ArticleId></ArticleIdList></Reference><Reference><Citation>Teinert J, Behne R, D&#x2019;Amore A, et al. . Generation and characterization of six human induced pluripotent stem cell lines (iPSC) from three families with AP4B1-associated hereditary spastic paraplegia (SPG47). Stem Cell Res. 2019;40:101575. 10.1016/j.scr.2019.101575</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.scr.2019.101575</ArticleId><ArticleId IdType="pmc">PMC7269118</ArticleId><ArticleId IdType="pubmed">31525725</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu PP, Denton KR, Pierson TM, Li XJ, Blackstone C.. Pharmacologic rescue of axon growth defects in a human iPSC model of hereditary spastic paraplegia SPG3A. Hum Mol Genet. 2014;23:5638-5648. 10.1093/hmg/ddu280</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu280</ArticleId><ArticleId IdType="pmc">PMC4189900</ArticleId><ArticleId IdType="pubmed">24908668</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Branguli F, Mishra HK, Prots I, et al. . Dysfunction of spatacsin leads to axonal pathology in SPG11-linked hereditary spastic paraplegia. Hum Mol Genet. 2014;23:4859-4874. 10.1093/hmg/ddu200</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu200</ArticleId><ArticleId IdType="pmc">PMC4140466</ArticleId><ArticleId IdType="pubmed">24794856</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimos JT, Rodolfa KT, Niakan KK, et al. . Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. 2008;321:1218-1221.</Citation><ArticleIdList><ArticleId IdType="pubmed">18669821</ArticleId></ArticleIdList></Reference><Reference><Citation>Hawrot J, Imhof S, Wainger BJ.. Modeling cell-autonomous motor neuron phenotypes in ALS using iPSCs. Neurobiol Dis. 2020;134:104680. 10.1016/j.nbd.2019.104680</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2019.104680</ArticleId><ArticleId IdType="pmc">PMC7002167</ArticleId><ArticleId IdType="pubmed">31759135</ArticleId></ArticleIdList></Reference><Reference><Citation>Burkhardt MF, Martinez FJ, Wright S, et al. . A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol Cell Neurosci. 2013;56:355-364. 10.1016/j.mcn.2013.07.007</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2013.07.007</ArticleId><ArticleId IdType="pmc">PMC4772428</ArticleId><ArticleId IdType="pubmed">23891805</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho R, Workman MJ, Mathkar P, et al. . Cross-comparison of human iPSC motor neuron models of familial and sporadic ALS reveals early and convergent transcriptomic disease signatures. Cell Syst. 2021;12:159-175.e9. 10.1016/j.cels.2020.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.10.010</ArticleId><ArticleId IdType="pmc">PMC7897311</ArticleId><ArticleId IdType="pubmed">33382996</ArticleId></ArticleIdList></Reference><Reference><Citation>Abati E, Citterio G, Bresolin N, Comi GP, Corti S.. Glial cells involvement in spinal muscular atrophy: could SMA be a neuroinflammatory disease? Neurobiol Dis. 2020;140:104870. 10.1016/j.nbd.2020.104870</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2020.104870</ArticleId><ArticleId IdType="pubmed">32294521</ArticleId></ArticleIdList></Reference><Reference><Citation>McGivern JV, Patitucci TN, Nord JA, et al. . Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production. Glia. 2013;61:1418-1428. 10.1002/glia.22522</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.22522</ArticleId><ArticleId IdType="pmc">PMC3941074</ArticleId><ArticleId IdType="pubmed">23839956</ArticleId></ArticleIdList></Reference><Reference><Citation>Sison SL, Patitucci TN, Seminary ER, et al. . Astrocyte-produced miR-146a as a mediator of motor neuron loss in spinal muscular atrophy. Hum Mol Genet. 2017;26:3409-3420. 10.1093/hmg/ddx230</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddx230</ArticleId><ArticleId IdType="pubmed">28637335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohuchi K, Funato M, Ando S, et al. . Impairment of oligodendrocyte lineages in spinal muscular atrophy model systems. Neuroreport. 2019;30:350-357. 10.1097/WNR.0000000000001206</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNR.0000000000001206</ArticleId><ArticleId IdType="pubmed">30724851</ArticleId></ArticleIdList></Reference><Reference><Citation>Adachi H, Kume A, Li M, et al. . Transgenic mice with an expanded CAG repeat controlled by the human AR promoter show polyglutamine nuclear inclusions and neuronal dysfunction without neuronal cell death. Hum Mol Genet. 2001;10:1039-1048. 10.1093/hmg/10.10.1039</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/10.10.1039</ArticleId><ArticleId IdType="pubmed">11331614</ArticleId></ArticleIdList></Reference><Reference><Citation>Mou Y, Dong Y, Chen Z, et al. . Impaired lipid metabolism in astrocytes underlies degeneration of cortical projection neurons in hereditary spastic paraplegia. Acta Neuropathol Commun. 2020;8:214. 10.1186/s40478-020-01088-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-020-01088-0</ArticleId><ArticleId IdType="pmc">PMC7720406</ArticleId><ArticleId IdType="pubmed">33287888</ArticleId></ArticleIdList></Reference><Reference><Citation>Orthmann-Murphy JL, Salsano E, Abrams CK, et al. . Hereditary spastic paraplegia is a novel phenotype for GJA12/GJC2 mutations. Brain. 2009;132:426-438. 10.1093/brain/awn328</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awn328</ArticleId><ArticleId IdType="pmc">PMC2640216</ArticleId><ArticleId IdType="pubmed">19056803</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Chun SJ, Boillee S, et al. . Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat Neurosci. 2008;11:251-253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3137510</ArticleId><ArticleId IdType="pubmed">18246065</ArticleId></ArticleIdList></Reference><Reference><Citation>Boillee S, Yamanaka K, Lobsiger CS, et al. . Onset and progression in inherited ALS determined by motor neurons and microglia. Science. 2006;312:1389-1392.</Citation><ArticleIdList><ArticleId IdType="pubmed">16741123</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer K, Ferraiuolo L, Miranda CJ, et al. . Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS. Proc Natl Acad Sci USA. 2014;111:829-832. 10.1073/pnas.1314085111</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1314085111</ArticleId><ArticleId IdType="pmc">PMC3896192</ArticleId><ArticleId IdType="pubmed">24379375</ArticleId></ArticleIdList></Reference><Reference><Citation>Birger A, Ottolenghi M, Perez L, Reubinoff B, Behar O.. ALS-related human cortical and motor neurons survival is differentially affected by Sema3A. Cell Death Dis. 2018;9:256. 10.1038/s41419-018-0294-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0294-6</ArticleId><ArticleId IdType="pmc">PMC5833799</ArticleId><ArticleId IdType="pubmed">29449528</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall CE, Yao Z, Choi M, et al. . Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS. Cell Rep. 2017;19:1739-1749. 10.1016/j.celrep.2017.05.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.05.024</ArticleId><ArticleId IdType="pmc">PMC5464993</ArticleId><ArticleId IdType="pubmed">28564594</ArticleId></ArticleIdList></Reference><Reference><Citation>Qian K, Huang H, Peterson A, et al. . Sporadic ALS astrocytes induce neuronal degeneration in vivo. Stem Cell Rep. 2017;8:843-855. 10.1016/j.stemcr.2017.03.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.03.003</ArticleId><ArticleId IdType="pmc">PMC5390239</ArticleId><ArticleId IdType="pubmed">28366455</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferraiuolo L, Meyer K, Sherwood TW, et al. . Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism. Proc Natl Acad Sci USA. 2016;113, E6496-E6505. 10.1073/pnas.1607496113</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607496113</ArticleId><ArticleId IdType="pmc">PMC5081600</ArticleId><ArticleId IdType="pubmed">27688759</ArticleId></ArticleIdList></Reference><Reference><Citation>Taga A, Dastgheyb R, Habela C, et al. . Role of human-induced pluripotent stem cell-derived spinal cord astrocytes in the functional maturation of motor neurons in a multielectrode array system. Stem Cells Transl Med. 2019;8(12):1272-1285. 10.1002/sctm.19-0147</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sctm.19-0147</ArticleId><ArticleId IdType="pmc">PMC6877769</ArticleId><ArticleId IdType="pubmed">31631575</ArticleId></ArticleIdList></Reference><Reference><Citation>Southam KA, King AE, Blizzard CA, McCormack GH, Dickson TC.. Microfluidic primary culture model of the lower motor neuron-neuromuscular junction circuit. J Neurosci Methods. 2013;218:164-169. 10.1016/j.jneumeth.2013.06.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jneumeth.2013.06.002</ArticleId><ArticleId IdType="pubmed">23774648</ArticleId></ArticleIdList></Reference><Reference><Citation>Ionescu A, Zahavi EE, Gradus T, Ben-Yaakov K, Perlson E.. Compartmental microfluidic system for studying muscle-neuron communication and neuromuscular junction maintenance. Eur J Cell Biol. 2016;95:69-88. 10.1016/j.ejcb.2015.11.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcb.2015.11.004</ArticleId><ArticleId IdType="pubmed">26689471</ArticleId></ArticleIdList></Reference><Reference><Citation>Stoklund Dittlau K, Krasnow EN, Fumagalli L, et al. . Human motor units in microfluidic devices are impaired by FUS mutations and improved by HDAC6 inhibition. Stem Cell Rep. 2021;16(9):2213-2227. 10.1016/j.stemcr.2021.03.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2021.03.029</ArticleId><ArticleId IdType="pmc">PMC8452598</ArticleId><ArticleId IdType="pubmed">33891869</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaki T, Uzel SGM, Kamm RD.. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons. Sci Adv. 2018;4:eaat5847. 10.1126/sciadv.aat5847</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciadv.aat5847</ArticleId><ArticleId IdType="pmc">PMC6179377</ArticleId><ArticleId IdType="pubmed">30324134</ArticleId></ArticleIdList></Reference><Reference><Citation>Vieira de S&#xe1; R, Canizares Luna M, Pasterkamp RJ.. Advances in central nervous system organoids: a focus on organoid-based models for motor neuron disease. Tissue Eng Part C Methods. 2021;27:213-224. 10.1089/ten.TEC.2020.0337</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/ten.TEC.2020.0337</ArticleId><ArticleId IdType="pubmed">33446055</ArticleId></ArticleIdList></Reference><Reference><Citation>Giandomenico SL, et al. . Cerebral organoids at the air-liquid interface generate diverse nerve tracts with functional output. Nat Neurosci. 2019;22:669-679. 10.1038/s41593-019-0350-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0350-2</ArticleId><ArticleId IdType="pmc">PMC6436729</ArticleId><ArticleId IdType="pubmed">30886407</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitahara T, Sakaguchi H, Morizane A, et al. . Axonal extensions along corticospinal tracts from transplanted human cerebral organoids. Stem Cell Rep. 2020;15:467-481. 10.1016/j.stemcr.2020.06.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2020.06.016</ArticleId><ArticleId IdType="pmc">PMC7419717</ArticleId><ArticleId IdType="pubmed">32679062</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogura T, Sakaguchi H, Miyamoto S, Takahashi J.. Three-dimensional induction of dorsal, intermediate and ventral spinal cord tissues from human pluripotent stem cells. Development. 2018;145(16):dev162214. 10.1242/dev.162214</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.162214</ArticleId><ArticleId IdType="pmc">PMC6124545</ArticleId><ArticleId IdType="pubmed">30061169</ArticleId></ArticleIdList></Reference><Reference><Citation>Hor JH, Soh ESY, Tan Ly, et al. . Cell cycle inhibitors protect motor neurons in an organoid model of spinal muscular atrophy. Cell Death Dis. 2018;9:1100. 10.1038/s41419-018-1081-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-1081-0</ArticleId><ArticleId IdType="pmc">PMC6204135</ArticleId><ArticleId IdType="pubmed">30368521</ArticleId></ArticleIdList></Reference><Reference><Citation>Kawada J, Kaneda S, Kirihara T, et al. . Generation of a motor nerve organoid with human stem cell-derived neurons. Stem Cell Rep. 2017;9:1441-1449. 10.1016/j.stemcr.2017.09.021</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.09.021</ArticleId><ArticleId IdType="pmc">PMC5831012</ArticleId><ArticleId IdType="pubmed">29107592</ArticleId></ArticleIdList></Reference><Reference><Citation>Duval N, Vaslin C, Barata T, et al. . BMP4 patterns Smad activity and generates stereotyped cell fate organization in spinal organoids. Development. 2019;146(14):dev175430. 10.1242/dev.175430</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/dev.175430</ArticleId><ArticleId IdType="pubmed">31239243</ArticleId></ArticleIdList></Reference><Reference><Citation>Spijkers XM, Svetlana PV, Dorleijn JC, et al. . A directional 3D neurite outgrowth model for studying motor axon biology and disease. Sci Rep. 2021;11:2080. 10.1038/s41598-021-81335-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-81335-z</ArticleId><ArticleId IdType="pmc">PMC7822896</ArticleId><ArticleId IdType="pubmed">33483540</ArticleId></ArticleIdList></Reference><Reference><Citation>Faustino Martins JM, Fischer C, Urzi A, et al. . Self-organizing 3D human trunk neuromuscular organoids. Cell Stem Cell. 2020;27:498. 10.1016/j.stem.2020.08.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2020.08.011</ArticleId><ArticleId IdType="pubmed">32888426</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen J, Revah O, Miura Y, et al. . Generation of functional human 3D cortico-motor assembloids. Cell. 2020;183:1913-1929.e26. 10.1016/j.cell.2020.11.017</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.11.017</ArticleId><ArticleId IdType="pmc">PMC8711252</ArticleId><ArticleId IdType="pubmed">33333020</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasca AM, Sloan SA, Clarke LE, et al. . Functional cortical neurons and astrocytes from human pluripotent stem cells in 3D culture. Nat Methods. 2015;12:671-678. 10.1038/nmeth.3415</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3415</ArticleId><ArticleId IdType="pmc">PMC4489980</ArticleId><ArticleId IdType="pubmed">26005811</ArticleId></ArticleIdList></Reference><Reference><Citation>Sloan SA, Darmanis S, Nina H, et al. . Human astrocyte maturation captured in 3D cerebral cortical spheroids derived from pluripotent stem cells. Neuron. 2017;95:779-790.e6. 10.1016/j.neuron.2017.07.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.035</ArticleId><ArticleId IdType="pmc">PMC5890820</ArticleId><ArticleId IdType="pubmed">28817799</ArticleId></ArticleIdList></Reference><Reference><Citation>Marton RM, Miura Y, Sloan SA, et al. . Differentiation and maturation of oligodendrocytes in human three-dimensional neural cultures. Nat Neurosci. 2019;22:484-491. 10.1038/s41593-018-0316-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0316-9</ArticleId><ArticleId IdType="pmc">PMC6788758</ArticleId><ArticleId IdType="pubmed">30692691</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinbeck JA, Jaiswal MK, Calder EL, et al. . Functional connectivity under optogenetic control allows modeling of human neuromuscular disease. Cell Stem Cell. 2016;18:134-143. 10.1016/j.stem.2015.10.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2015.10.002</ArticleId><ArticleId IdType="pmc">PMC4707991</ArticleId><ArticleId IdType="pubmed">26549107</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellmann J, Goswami RY, Girardo S, et al. . A customizable microfluidic platform for medium-throughput modeling of neuromuscular circuits. Biomaterials. 2019;225:119537. 10.1016/j.biomaterials.2019.119537</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biomaterials.2019.119537</ArticleId><ArticleId IdType="pmc">PMC7294901</ArticleId><ArticleId IdType="pubmed">31614290</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaki T, Uzel SGM, Kamm RD.. On-chip 3D neuromuscular model for drug screening and precision medicine in neuromuscular disease. Nat Protoc. 2020;15:421-449. 10.1038/s41596-019-0248-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-019-0248-1</ArticleId><ArticleId IdType="pubmed">31932771</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, Kralj JM, Zou P, et al. . All-optical electrophysiology for high-throughput functional characterization of a human iPSC-derived motor neuron model of ALS. Stem Cell Rep. 2018;10:1991-2004. 10.1016/j.stemcr.2018.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2018.04.020</ArticleId><ArticleId IdType="pmc">PMC5993648</ArticleId><ArticleId IdType="pubmed">29779896</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyvarinen T, Hyysalo A, Kapucu FE, et al. . Functional characterization of human pluripotent stem cell-derived cortical networks differentiated on laminin-521 substrate: comparison to rat cortical cultures. Sci Rep. 2019;9:17125. 10.1038/s41598-019-53647-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-53647-8</ArticleId><ArticleId IdType="pmc">PMC6868015</ArticleId><ArticleId IdType="pubmed">31748598</ArticleId></ArticleIdList></Reference><Reference><Citation>Negri J, Menon V, Young-Pearse TL.. Assessment of spontaneous neuronal activity in vitro using multi-well multi-electrode arrays: implications for assay development. eNeuro. 2020;7(1):ENEURO.0080-19.2019. 10.1523/ENEURO.0080-19.2019</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/ENEURO.0080-19.2019</ArticleId><ArticleId IdType="pmc">PMC6984810</ArticleId><ArticleId IdType="pubmed">31896559</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrasate M, Finkbeiner S.. Automated microscope system for determining factors that predict neuronal fate. Proc Natl Acad Sci USA. 2005;102:3840-3845. 10.1073/pnas.0409777102</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0409777102</ArticleId><ArticleId IdType="pmc">PMC553329</ArticleId><ArticleId IdType="pubmed">15738408</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilican B, Serio A, Barmada SJ, et al. . Mutant induced pluripotent stem cell lines recapitulate aspects of TDP-43 proteinopathies and reveal cell-specific vulnerability. Proc Natl Acad Sci USA. 2012;109:5803-5808. 10.1073/pnas.1202922109</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1202922109</ArticleId><ArticleId IdType="pmc">PMC3326463</ArticleId><ArticleId IdType="pubmed">22451909</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura K, Yada Y, Izumi Y, et al. . Prediction model of amyotrophic lateral sclerosis by deep learning with patient induced pluripotent stem cells. Ann Neurol. 2021;89(6):1226-1233. 10.1002/ana.26047</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26047</ArticleId><ArticleId IdType="pmc">PMC8247989</ArticleId><ArticleId IdType="pubmed">33565152</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, Ishikawa M, Otomo A, et al. . Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat Med. 2018;24:1579-1589. 10.1038/s41591-018-0140-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Rehbach K, Kesavan J, Hauser S, et al. . Multiparametric rapid screening of neuronal process pathology for drug target identification in HSP patient-specific neurons. Sci Rep. 2019;9:9615. 10.1038/s41598-019-45246-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-45246-4</ArticleId><ArticleId IdType="pmc">PMC6610147</ArticleId><ArticleId IdType="pubmed">31270336</ArticleId></ArticleIdList></Reference><Reference><Citation>Brancati G, Treutlein B, Camp JG.. Resolving neurodevelopmental and vision disorders using organoid single-cell multi-omics. Neuron. 2020;107:1000-1013. 10.1016/j.neuron.2020.09.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2020.09.001</ArticleId><ArticleId IdType="pubmed">32970995</ArticleId></ArticleIdList></Reference><Reference><Citation>Hillman EMC, Voleti V, Li W, Yu H.. Light-sheet microscopy in neuroscience. Annu Rev Neurosci. 2019;42:295-313. 10.1146/annurev-neuro-070918-050357</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-neuro-070918-050357</ArticleId><ArticleId IdType="pmc">PMC6800245</ArticleId><ArticleId IdType="pubmed">31283896</ArticleId></ArticleIdList></Reference><Reference><Citation>Costamagna G, Comi GP, Corti S.. Advancing drug discovery for neurological disorders using iPSC-derived neural organoids. Int J Mol Sci. 2021;22(5):2659. 10.3390/ijms22052659</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22052659</ArticleId><ArticleId IdType="pmc">PMC7961877</ArticleId><ArticleId IdType="pubmed">33800815</ArticleId></ArticleIdList></Reference><Reference><Citation>Bakkar N, Kovalik T, Lorenzini I, et al. . Artificial intelligence in neurodegenerative disease research: use of IBM Watson to identify additional RNA-binding proteins altered in amyotrophic lateral sclerosis. Acta Neuropathol. 2018;135:227-247. 10.1007/s00401-017-1785-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1785-8</ArticleId><ArticleId IdType="pmc">PMC5773659</ArticleId><ArticleId IdType="pubmed">29134320</ArticleId></ArticleIdList></Reference><Reference><Citation>Myszczynska MA, Ojamies PJ, Lacoste AMB, et al. . Applications of machine learning to diagnosis and treatment of neurodegenerative diseases. Nat Rev Neurol. 2020;16:440-456. 10.1038/s41582-020-0377-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0377-8</ArticleId><ArticleId IdType="pubmed">32669685</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai JI, Leman LJ, Ku S, et al. . Cyclic tetrapeptide HDAC inhibitors as potential therapeutics for spinal muscular atrophy: screening with iPSC-derived neuronal cells. Bioorg Med Chem Lett. 2017;27:3289-3293. 10.1016/j.bmcl.2017.06.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2017.06.027</ArticleId><ArticleId IdType="pubmed">28648462</ArticleId></ArticleIdList></Reference><Reference><Citation>Garbes L, Heesan L, Holker I, et al. . VPA response in SMA is suppressed by the fatty acid translocase CD36. Hum Mol Genet. 2013;22:398-407. 10.1093/hmg/dds437</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/dds437</ArticleId><ArticleId IdType="pubmed">23077215</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida M, Kitaoka S, Egawa N, et al. . Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs. Stem Cell Rep. 2015;4:561-568. 10.1016/j.stemcr.2015.02.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2015.02.010</ArticleId><ArticleId IdType="pmc">PMC4400613</ArticleId><ArticleId IdType="pubmed">25801509</ArticleId></ArticleIdList></Reference><Reference><Citation>Son YS, Choi K, Lee H, et al. . A SMN2 splicing modifier rescues the disease phenotypes in an in vitro human spinal muscular atrophy model. Stem Cells Dev. 2019;28:438-453. 10.1089/scd.2018.0181</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/scd.2018.0181</ArticleId><ArticleId IdType="pubmed">30667343</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando S, Suzuki S, Okubo S, et al. . Discovery of a CNS penetrant small molecule SMN2 splicing modulator with improved tolerability for spinal muscular atrophy. Sci Rep. 2020;10:17472. 10.1038/s41598-020-74346-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-74346-9</ArticleId><ArticleId IdType="pmc">PMC7562719</ArticleId><ArticleId IdType="pubmed">33060681</ArticleId></ArticleIdList></Reference><Reference><Citation>d&#x2019;Ydewalle C, Ramos DM, Pyles NJ, et al. . The antisense transcript SMN-AS1 regulates SMN expression and is a novel therapeutic target for spinal muscular atrophy. Neuron. 2017;93:66-79. 10.1016/j.neuron.2016.11.033</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.11.033</ArticleId><ArticleId IdType="pmc">PMC5223741</ArticleId><ArticleId IdType="pubmed">28017471</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez A, Crisafulli SG, Rizzuti M, et al. . Investigation of new morpholino oligomers to increase survival motor neuron protein levels in spinal muscular atrophy. Int J Mol Sci. 2018;19:167. 10.3390/ijms19010167</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19010167</ArticleId><ArticleId IdType="pmc">PMC5796116</ArticleId><ArticleId IdType="pubmed">29316633</ArticleId></ArticleIdList></Reference><Reference><Citation>Osman EY, Washington CW, Kaifer KA, et al. . Optimization of morpholino antisense oligonucleotides targeting the intronic repressor element1 in spinal muscular atrophy. Mol Ther. 2016;24:1592-1601. 10.1038/mt.2016.145</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mt.2016.145</ArticleId><ArticleId IdType="pmc">PMC5113110</ArticleId><ArticleId IdType="pubmed">27401142</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Hu Z, Qiu L, et al. . Seamless genetic conversion of SMN2 to SMN1 via CRISPR/Cpf1 and single-stranded oligodeoxynucleotides in spinal muscular atrophy patient-specific induced pluripotent stem cells. Hum Gene Ther. 2018;29:1252-1263. 10.1089/hum.2017.255</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/hum.2017.255</ArticleId><ArticleId IdType="pubmed">29598153</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo CJ, Maier VK, Davey R, et al. . Gene activation of SMN by selective disruption of lncRNA-mediated recruitment of PRC2 for the treatment of spinal muscular atrophy. Proc Natl Acad Sci USA. 2017;114:E1509-E1518. 10.1073/pnas.1616521114</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1616521114</ArticleId><ArticleId IdType="pmc">PMC5338378</ArticleId><ArticleId IdType="pubmed">28193854</ArticleId></ArticleIdList></Reference><Reference><Citation>Rusmini P, Cortese K, Crippa V, et al. . Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration. Autophagy. 2019;15:631-651. 10.1080/15548627.2018.1535292</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2018.1535292</ArticleId><ArticleId IdType="pmc">PMC6526812</ArticleId><ArticleId IdType="pubmed">30335591</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozner T, Schray A, Regensburger M, et al. . Tideglusib rescues neurite pathology of SPG11 iPSC derived cortical neurons. Front Neurosci. 2018;12:914. 10.3389/fnins.2018.00914</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00914</ArticleId><ArticleId IdType="pmc">PMC6291617</ArticleId><ArticleId IdType="pubmed">30574063</ArticleId></ArticleIdList></Reference><Reference><Citation>Wainger BJ, Kiskinis E, Mellin C, et al. . Intrinsic membrane hyperexcitability of amyotrophic lateral sclerosis patient-derived motor neurons. Cell Rep. 2014;7:1-11. 10.1016/j.celrep.2014.03.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2014.03.019</ArticleId><ArticleId IdType="pmc">PMC4023477</ArticleId><ArticleId IdType="pubmed">24703839</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiskinis E, Sandoe J, Williams LA, et al. . Pathways disrupted in human ALS motor neurons identified through genetic correction of mutant SOD1. Cell Stem Cell. 2014;14:781-795. 10.1016/j.stem.2014.03.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stem.2014.03.004</ArticleId><ArticleId IdType="pmc">PMC4653065</ArticleId><ArticleId IdType="pubmed">24704492</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhinge A, Namboori SC, Zhang X, VanDongen AMJ, Stanton LW.. Genetic correction of SOD1 mutant iPSCs reveals ERK and JNK activated AP1 as a driver of neurodegeneration in amyotrophic lateral sclerosis. Stem Cell Rep. 2017;8:856-869. 10.1016/j.stemcr.2017.02.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.02.019</ArticleId><ArticleId IdType="pmc">PMC5390134</ArticleId><ArticleId IdType="pubmed">28366453</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X, Roet KCD, Zhang L, et al. . Human amyotrophic lateral sclerosis excitability phenotype screen: target discovery and validation. Cell Rep. 2017;35:109224. 10.1016/j.celrep.2021.109224</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109224</ArticleId><ArticleId IdType="pmc">PMC8209673</ArticleId><ArticleId IdType="pubmed">34107252</ArticleId></ArticleIdList></Reference><Reference><Citation>Egawa N, Kitaoka S, Tsukita K, et al. . Drug screening for ALS using patient-specific induced pluripotent stem cells. Sci Transl Med. 2012;4:145ra104. 10.1126/scitranslmed.3004052</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3004052</ArticleId><ArticleId IdType="pubmed">22855461</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Serio A, Arjun A, et al. . Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat Chem Biol. 2014;10:677-685. 10.1038/nchembio.1563</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1563</ArticleId><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang MY, Markmiller S, Vu AQ, et al. . Small-molecule modulation of TDP-43 recruitment to stress granules prevents persistent TDP-43 accumulation in ALS/FTD. Neuron. 2019;103:802-819.e11. 10.1016/j.neuron.2019.05.048</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2019.05.048</ArticleId><ArticleId IdType="pmc">PMC6728177</ArticleId><ArticleId IdType="pubmed">31272829</ArticleId></ArticleIdList></Reference><Reference><Citation>Fazal R, Boeynaems S, Swijsen A, et al. . HDAC6 inhibition restores TDP-43 pathology and axonal transport defects in human motor neurons with TARDBP mutations. EMBO J. 2021;40:e106177. 10.15252/embj.2020106177</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2020106177</ArticleId><ArticleId IdType="pmc">PMC8013789</ArticleId><ArticleId IdType="pubmed">33694180</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo W, Naujock M, Fumagalli L, et al. . HDAC6 inhibition reverses axonal transport defects in motor neurons derived from FUS-ALS patients. Nat Commun. 2017;8:861. 10.1038/s41467-017-00911-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00911-y</ArticleId><ArticleId IdType="pmc">PMC5636840</ArticleId><ArticleId IdType="pubmed">29021520</ArticleId></ArticleIdList></Reference><Reference><Citation>Naumann M, Pal A, Goswami A, et al. . Impaired DNA damage response signaling by FUS-NLS mutations leads to neurodegeneration and FUS aggregate formation. Nat Commun. 2018;9:335. 10.1038/s41467-017-02299-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-02299-1</ArticleId><ArticleId IdType="pmc">PMC5780468</ArticleId><ArticleId IdType="pubmed">29362359</ArticleId></ArticleIdList></Reference><Reference><Citation>Marrone L, Drexler HCA, Wang J, et al. . FUS pathology in ALS is linked to alterations in multiple ALS-associated proteins and rescued by drugs stimulating autophagy. Acta Neuropathol. 2019;138:67-84. 10.1007/s00401-019-01998-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-019-01998-x</ArticleId><ArticleId IdType="pmc">PMC6570784</ArticleId><ArticleId IdType="pubmed">30937520</ArticleId></ArticleIdList></Reference><Reference><Citation>Naujock M, Stanslowsky N, Bufler S, et al. . 4-Aminopyridine induced activity rescues hypoexcitable motor neurons from amyotrophic lateral sclerosis patient-derived induced pluripotent stem cells. Stem Cells. 2016;34:1563-1575. 10.1002/stem.2354</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/stem.2354</ArticleId><ArticleId IdType="pubmed">26946488</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R, Lu Y, Gendron TF, et al. . Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92:383-391. 10.1016/j.neuron.2016.09.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y, Lin S, Staats KA, et al. . Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons. Nat Med. 2018;24:313-325. 10.1038/nm.4490</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.4490</ArticleId><ArticleId IdType="pmc">PMC6112156</ArticleId><ArticleId IdType="pubmed">29400714</ArticleId></ArticleIdList></Reference><Reference><Citation>Khosravi B, LaClair KD, Kiemenschneider H, et al. . Cell-to-cell transmission of C9orf72 poly-(Gly-Ala) triggers key features of ALS/FTD. EMBO J. 2020;39(8):e102811. 10.15252/embj.2019102811</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.2019102811</ArticleId><ArticleId IdType="pmc">PMC7156967</ArticleId><ArticleId IdType="pubmed">32175624</ArticleId></ArticleIdList></Reference><Reference><Citation>Donnelly CJ, Zhang PW, Pham JT, et al. . RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention. Neuron. 2013;80:415-428. 10.1016/j.neuron.2013.10.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2013.10.015</ArticleId><ArticleId IdType="pmc">PMC4098943</ArticleId><ArticleId IdType="pubmed">24139042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagier-Tourenne C, Baughn M, Rigo F, et al. . Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci USA. 2013;110:E4530-E4539. 10.1073/pnas.1318835110</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1318835110</ArticleId><ArticleId IdType="pmc">PMC3839752</ArticleId><ArticleId IdType="pubmed">24170860</ArticleId></ArticleIdList></Reference><Reference><Citation>Sareen D, O\'Rourke JG, Meera P, et al. . Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion. Sci Transl Med. 2013;5:208ra149. 10.1126/scitranslmed.3007529</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.3007529</ArticleId><ArticleId IdType="pmc">PMC4090945</ArticleId><ArticleId IdType="pubmed">24154603</ArticleId></ArticleIdList></Reference><Reference><Citation>Imamura K, Izumi Y, Watanabe A, et al. . The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis. Sci Transl Med. 2017;99(391):eaaf3962. 10.1126/scitranslmed.aaf3962</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf3962</ArticleId><ArticleId IdType="pubmed">28539470</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimori K, Ishikawa M, Otomo A, et al. . Modeling sporadic ALS in iPSC-derived motor neurons identifies a potential therapeutic agent. Nat Med. 2018;24:1579-1589. 10.1038/s41591-018-0140-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-018-0140-5</ArticleId><ArticleId IdType="pubmed">30127392</ArticleId></ArticleIdList></Reference><Reference><Citation>Finkel RS, Mercuri E, Darras BT, et al. . Nusinersen versus sham control in infantile-onset spinal muscular atrophy. N Engl J Med. 2017;377:1723-1732. 10.1056/NEJMoa1702752</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1702752</ArticleId><ArticleId IdType="pubmed">29091570</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra HK, Prots I, Havlicek S, et al. . GSK3ss-dependent dysregulation of neurodevelopment in SPG11-patient induced pluripotent stem cell model. Ann Neurol. 2016;79:826-840. 10.1002/ana.24633</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24633</ArticleId><ArticleId IdType="pmc">PMC5084783</ArticleId><ArticleId IdType="pubmed">26971897</ArticleId></ArticleIdList></Reference><Reference><Citation>Amoroso MW, Croft GF, Williams DJ, et al. . Accelerated high-yield generation of limb-innervating motor neurons from human stem cells. J Neurosci. 2016;33:574-586. 10.1523/JNEUROSCI.0906-12.2013</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0906-12.2013</ArticleId><ArticleId IdType="pmc">PMC3711539</ArticleId><ArticleId IdType="pubmed">23303937</ArticleId></ArticleIdList></Reference><Reference><Citation>Dasen JS, De Camilli A, Wang B, Tucker PW, Jessell TM.. Hox repertoires for motor neuron diversity and connectivity gated by a single accessory factor, FoxP1. Cell. 2008;134:304-316. 10.1016/j.cell.2008.06.019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.06.019</ArticleId><ArticleId IdType="pubmed">18662545</ArticleId></ArticleIdList></Reference><Reference><Citation>Thaler JP, Lee SK, Jurata LW, Gill GN, Pfaff SL.. LIM factor Lhx3 contributes to the specification of motor neuron and interneuron identity through cell-type-specific protein-protein interactions. Cell. 2002;110:237-249. 10.1016/s0092-8674(02)00823-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0092-8674(02)00823-1</ArticleId><ArticleId IdType="pubmed">12150931</ArticleId></ArticleIdList></Reference><Reference><Citation>Thiry L, Hamel R, Pluchino S, Durcan T, Stifani S.. Characterization of human iPSC-derived spinal motor neurons by single-cell RNA sequencing. Neuroscience. 2020;450:57-70. 10.1016/j.neuroscience.2020.04.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2020.04.041</ArticleId><ArticleId IdType="pubmed">32380268</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>